PharmaDeals Reports

PharmaDeals' new report on valuation provides an essential grounding in how to use proven and reliable methods for maximising the value of pharmaceutical and biotechnology projects.

Guide to Valuation Pharmaceutical Licensing Deals
This guide provides essential insight on the issues of most concern to business development and licensing professionals worldwide. It fully addresses concepts in financial modelling and provides detailed valuation examples.
Published
Request more information pdenquiries@uk.imshealth.com
Building on PharmaDeals' established reputation in the area of deal and alliances, this report:
  • Provides a thorough understanding of robust valuation methodologies
  • Enables more rigorous economic portfolio analysis
  • Assists the formulation of attractive deal structures
  • Permits accurate comparison of alternative deals
  • Highlights the value creation process
In addition, the report provides a set of deal term benchmarks by stages of development which can be used as valuable reference points.

No template specified or missing template file for block "Custom Right: Access iReports Now"

PharmaDeals Trends and Analysis Series
Analysis of Deal Making in Vaccines
Analysis of Deals in Neurodegenerative Diseases
Analysis of Oncology Deals: Trends in Deal Structures and Valuations
IQVIA™ Pharma Deals